Health
Johnson & Johnson’s COVID-19 vaccine shows promising response in early trial after one dose – WSYM-TV
Results from early stage trials of Johnson & Johnsons COVID-19 vaccine are promising, showing the one-dose vaccine generates an immune response in nearly all volunteers, with minimal side effects.
The company plans to release more details in a few weeks, and apply for emergency use authorization from the FDA in February.
Researchers say
Phase 1-2 of the vaccine showed either one or two doses of the vaccine generated both antibody and T-cell responses against the coronavirus. The vaccines efficacy,…
-
General18 hours agoChina and Philippines trade blame over latest South China Sea clash
-
Noosa News22 hours agoBrisbane rising on global rankings, but still behind southern capitals
-
General18 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire
-
Noosa News8 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones